Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Daniel O'Day, Pascal Soriot, Roland Diggelmann

Premium

Roche has appointed Daniel O'Day, current COO of Roche Diagnostics, to be COO of Roche Pharma. O'Day replaces Pascal Soriot, who has left Roche to become CEO of AstraZeneca. Roland Diggelmann will succeed O'Day as COO of Roche Diagnostics, the company said.

Diggelmann, who currently is head of the Asia-Pacific region within Roche Diagnostics, also has been appointed to be a new member of the executive committee by the board of directors. Diggelmann joined Roche in 2008, and he formerly worked in sales and marketing in Europe and the Asia-Pacific region with Sulzer Medica/Centerpulse and Zimmer.

O'Day has held various positions at Roche since he started with Roche Pharmaceuticals in 1987, including serving as head of molecular diagnostics.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.